Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $202.95 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $109.28 | 1 | $0 (2022) |
| Omeros Corporation | $33.63 | 2 | $0 (2018) |
| Advanced Accelerator Applications | $32.78 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $14.57 | 1 | $0 (2023) |
| Genentech USA, Inc. | $12.69 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.57 | 1 | GlaxoSmithKline, LLC. ($14.57) |
| 2022 | $121.97 | 2 | Otsuka America Pharmaceutical, Inc. ($109.28) |
| 2019 | $32.78 | 2 | Advanced Accelerator Applications ($32.78) |
| 2018 | $16.05 | 1 | Omeros Corporation ($16.05) |
| 2017 | $17.58 | 1 | Omeros Corporation ($17.58) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2022 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, Phesgo | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: BioOncology | ||||||
| 04/26/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $109.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2019 | Advanced Accelerator Applications | Lutathera (Drug), Netspot | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Radioactive targeted therapy - Neuroendocrine tumors | ||||||
| 11/20/2019 | Advanced Accelerator Applications | Lutathera (Drug), Netspot | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Radioactive targeted therapy - Neuroendocrine tumors | ||||||
| 05/17/2018 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: Ophthalmology | ||||||
| 12/21/2017 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 175 | 367 | $80,240 | $25,980 |
| 2020 | 3 | 374 | 883 | $193,875 | $65,133 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 85 | 272 | $53,040 | $16,567 | 31.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 44 | 46 | $14,950 | $5,210 | 34.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 46 | 49 | $12,250 | $4,203 | 34.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 189 | 673 | $128,185 | $41,467 | 32.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 156 | 178 | $57,850 | $20,968 | 36.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 29 | 32 | $7,840 | $2,699 | 34.4% |
About Dr. Robert Gordon, D.O
Dr. Robert Gordon, D.O is a Pulmonary Disease healthcare provider based in Stratford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013945799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gordon, D.O has received a total of $202.95 in payments from pharmaceutical and medical device companies, with $14.57 received in 2023. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($202.95).
As a Medicare-enrolled provider, Gordon has provided services to 549 Medicare beneficiaries, totaling 1,250 services with total Medicare billing of $91,114. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Stratford, NJ
- Active Since 06/29/2006
- Last Updated 02/06/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1013945799
Products in Payments
- ABILIFY MAINTENA (Drug) $109.28
- Omidria (Drug) $33.63
- Lutathera (Drug) $32.78
- AREXVY (Drug) $14.57
- Perjeta (Biological) $12.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.